AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
What made Moderna stock pop 10% on Tuesday?
April 10, 2024 02:37 AM AEST| By InvezzModerna Inc (NASDAQ: MRNA) popped as much as 10% on Tuesday after a Jefferies analyst made upbeat remarks on new data for its experimental vaccine for head and neck cancer. MRNA-4157 has potential beyond melanoma The biotech giant reported positive e...
Ocugen stock price is flying: beware of this crucial OCGN risk
April 07, 2024 06:06 PM AEST| By InvezzOcugen (NASDAQ: OCGN) stock price has been one of the best-performing companies in Wall Street this year. It has jumped by more than 218% in 2024, beating some of the best-known brands like Nvidia and Amazon. This surge has boosted its total market c...
Candel Therapeutics stock soars 30%: find out more
April 05, 2024 11:28 PM AEDT| By InvezzCandel Therapeutics Inc is up roughly 30% in premarket on Friday after reporting positive interim data for its experimental treatment of non-metastatic pancreatic cancer. CAN-2409 data sends Candel Therapeutics stock up Patients on CAN-2409 showed a...
Johnson & Johnson to buy Shockwave Medical for $12.5 billion
April 05, 2024 10:18 PM AEDT| By InvezzShockwave Medical Inc (NASDAQ: SWAV) is in the green today after Johnson & Johnson (NYSE: JNJ) said it will buy the medical device maker for $12.5 billion. Shockwave Medical stock priced at a premium The all-cash agreement values each share of Sh...
Top three US healthcare stocks to buy in April
April 04, 2024 07:54 PM AEDT| By InvezzAs we look forward to celebrating World Health Day on April 7th, these are the top three healthcare US companies we think you should be watching for your financial health. 1. Lilly (Eli) & Co. Eli Lilly and Company, based in Indianapolis, d...
Amcor Powers Up for Healthcare Boom: Expands Thermoforming Capacity in North America
February 01, 2024 07:32 PM AEDT| By Team Kalkine MediaAmcor, a global leader in packaging solutions, has recently revealed plans to expand its thermoforming production capacity in North America. This strategic move is driven by the increasing demands of its healthcare customers in the region. As the hea...
Cramer reacts to Eli Lilly’s telehealth service for weight-loss drug
January 05, 2024 09:29 AM AEDT| By InvezzEli Lilly & Co (NYSE: LLY) was the talk of the market on Thursday after the pharmaceutical giant launched LillyDirect – a website that will enable patients to get prescription for its weight-loss drug directly from a telehealth provider. Cramer r...
After a bruising 2023, Bristol-Myers Squibb (BMY) forges a risky M&A strategy
December 27, 2023 03:02 PM AEDT| By InvezzBristol-Myers Squibb (NYSE: BMY), the giant pharmaceutical company, had a difficult year as its stock tanked. Its shares crashed by over 28% in 2023, becoming one of the top laggards of the S&P 500 index. It has dropped by more than 34% in 2023,...
AbbVie bolsters portfolio with $10.1 billion ImmunoGen buyout for cancer therapy
December 02, 2023 12:50 AM AEDT| By InvezzAbbVie has announced its acquisition of ImmunoGen for $10.1 billion in cash, marking a strategic move amidst rising competition for their leading treatment, Humira. ImmunoGen’s Elahere, part of the innovative class of antibody-drug conjugates (...
Days after US and UK approval, Eli Lilly’s Tirzepatide approved in the EU
November 11, 2023 05:05 AM AEDT| By InvezzEli Lilly (LLY) stock price movement has experienced a whirlwind since Wednesday’s approval of its diabetes medication, tirzepatide, for chronic weight management in the United States and the United Kingdom. The stock, took a dive on Thursday t...
Find out why these biotechnology firms surpassed market gains
October 20, 2023 09:06 PM AEDT| By Akanksha VashishtSummary,The Nasdaq composite index fell by 1% on Thursday.,Cidara Therapeutics Inc. reported a revenue of US$7.6 million for Q2 2023.,INmune Bio Inc. reported a net loss attributed to common stockholders of around US$6.5 million.,Biotechnology firms...
These Nasdaq-listed healthcare stocks beat Monday’s market gains
October 03, 2023 09:38 PM AEDT| By Akanksha VashishtSummary,The Nasdaq Composite Index rose by 0.67% on Monday, while the Nasdaq Healthcare Index fell by 0.67%.,Spok Holdings Inc., a healthcare communications provider, gained 1.75% intraday at Monday’s close.,LeMaitre Vascular Inc., a medical equipmen...
Blue Shield of California to trim its partnership with CVS Health
August 18, 2023 03:16 AM AEST| By InvezzBlue Shield of California plans on trimming its partnership with CVS Health Corp (NYSE: CVS) to cut costs. Shares of the healthcare company are down 8.0% on Thursday. Blue Shield to switch to Amazon and Cost Plus Drugs Blue Shield has been working wi...
UNH wins provisional clearance from U.K. CMA to acquire EMIS
August 12, 2023 03:03 AM AEST| By InvezzUnitedHealth Group Inc (NYSE: UNH) is in the green this morning after the British regulator provisionally cleared its £1.2 billion acquisition of EMIS Group (LON: EMIS). CMA says the takeover will not hurt competition It’s been a year sinc...
Eli Lilly stock is a ‘buy’ after its blockbuster Q2
August 10, 2023 02:44 AM AEST| By InvezzEli Lilly & Co (NYSE: LLY) has already gained 45% year-to-date but a Jefferies analyst is convinced that the stock is not out of juice just yet. Eli Lilly stock could climb another 18% On Wednesday, Akash Tewari upgraded the pharmaceutical behemo...
Novo Nordisk shares jump another 17% on the back of obesity drug
August 09, 2023 01:20 AM AEST| By InvezzShares of Novo Nordisk A/S (NYSE: NVO) are up 17% this morning after the pharmaceutical behemoth reported results of its “SELECT” trial. Wegovy lowers the risk of cardiovascular events On Tuesday, the multinational cited data from that la...
Hims & Hers stock price has gone parabolic: Is it a good buy?
August 08, 2023 10:30 PM AEST| By InvezzHims & Hers (NYSE: HIMS) stock price bounced back after the company published strong results and boosted its forward guidance. The shares closed the day at $7.90 and then surged by over 19% to $9.20. Hims & Hers earnings download Hims &...
As Cassava Sciences (SAVA) stock slips, is it safe to buy the dip?
August 08, 2023 03:14 AM AEST| By InvezzCassava Sciences (NASDAQ: SAVA) stock price sell-off intensified as the recent momentum faded. SAVA shares plunged to a low of $18.30 on Monday, the lowest level since August 8th of this year. It has dropped by more than 63% from its highest level in...
Haleon share price analysis: where technicals meet fundamentals
August 02, 2023 08:17 PM AEST| By InvezzHaleon (LON: HLN) share price retreated even after the company published strong financial results and boosted its forward guidance. The stock plunged to a low of 323p, the lowest point since July 19th. It has dropped by more than 5% from the highest...
Top-performing Healthcare Stocks in July 2023
July 24, 2023 11:50 PM AEST| By Team Kalkine MediaTop-performing Healthcare Stocks in July 2023
